Skip to contentA
Axogen, Inc.
A
AXGNAxogen, Inc. Q4 2014 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$4.79M$4.79Mderived+60.6% vs Q4 2013 Net Income-$6.49M-$6.49MderivedN/M vs Q4 2013 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axogen, Inc. · CIK 805928 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$3,836,729+60.6% Operating Incomederived-$2,709,000N/M Operating Cash Flowderived-$2,431,574N/M Free Cash Flowderived-$2,630,744N/M Margins · derivedGross margin80.0%+0.0 pt vs Q4 2013
Operating margin-56.5%+37.2 pt vs Q4 2013
Net margin-135.4%+2.2 pt vs Q4 2013
ended Dec 31, 2014 · filed Mar 5, 2015 · 64 d after period end